Age-Related Macular Degeneration Global Market Report 2025

Age-Related Macular Degeneration Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on age-related macular degeneration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for age-related macular degeneration ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The age-related macular degeneration market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Wet Age-Related Macular Degeneration (AMD); Dry Age-Related Macular Degeneration (AMD)

2) By Drug: Eylea; Lucentis; Avastin; Other Products

3) By Route Of Administration: Intravenous; Intravitreal

4) By Distribution Channel: Hospital Pharmacy; Specialty Pharmacy; Online Pharmacy

Subsegments:

1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections; Photodynamic Therapy; Laser Surgery

2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements; Low Vision Aids; Therapies For Geographic Atrophy

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Novartis AG; Bayer AG; Pfizer Inc.; Bausch Health Companies Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Age-Related Macular Degeneration Market Characteristics
3. Age-Related Macular Degeneration Market Trends And Strategies
4. Age-Related Macular Degeneration Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Age-Related Macular Degeneration Growth Analysis And Strategic Analysis Framework
5.1. Global Age-Related Macular Degeneration PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Age-Related Macular Degeneration Market Growth Rate Analysis
5.4. Global Age-Related Macular Degeneration Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Age-Related Macular Degeneration Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Age-Related Macular Degeneration Total Addressable Market (TAM)
6. Age-Related Macular Degeneration Market Segmentation
6.1. Global Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Wet Age-Related Macular Degeneration (AMD)
Dry Age-Related Macular Degeneration (AMD)
6.2. Global Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Eylea
Lucentis
Avastin
Other Products
6.3. Global Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Intravitreal
6.4. Global Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Specialty Pharmacy
Online Pharmacy
6.5. Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-VEGF Injections
Photodynamic Therapy
Laser Surgery
6.6. Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nutritional Supplements
Low Vision Aids
Therapies For Geographic Atrophy
7. Age-Related Macular Degeneration Market Regional And Country Analysis
7.1. Global Age-Related Macular Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Age-Related Macular Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Age-Related Macular Degeneration Market
8.1. Asia-Pacific Age-Related Macular Degeneration Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Age-Related Macular Degeneration Market
9.1. China Age-Related Macular Degeneration Market Overview
9.2. China Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Age-Related Macular Degeneration Market
10.1. India Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Age-Related Macular Degeneration Market
11.1. Japan Age-Related Macular Degeneration Market Overview
11.2. Japan Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Age-Related Macular Degeneration Market
12.1. Australia Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Age-Related Macular Degeneration Market
13.1. Indonesia Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Age-Related Macular Degeneration Market
14.1. South Korea Age-Related Macular Degeneration Market Overview
14.2. South Korea Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Age-Related Macular Degeneration Market
15.1. Western Europe Age-Related Macular Degeneration Market Overview
15.2. Western Europe Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Age-Related Macular Degeneration Market
16.1. UK Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Age-Related Macular Degeneration Market
17.1. Germany Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Age-Related Macular Degeneration Market
18.1. France Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Age-Related Macular Degeneration Market
19.1. Italy Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Age-Related Macular Degeneration Market
20.1. Spain Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Age-Related Macular Degeneration Market
21.1. Eastern Europe Age-Related Macular Degeneration Market Overview
21.2. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Age-Related Macular Degeneration Market
22.1. Russia Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Age-Related Macular Degeneration Market
23.1. North America Age-Related Macular Degeneration Market Overview
23.2. North America Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Age-Related Macular Degeneration Market
24.1. USA Age-Related Macular Degeneration Market Overview
24.2. USA Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Age-Related Macular Degeneration Market
25.1. Canada Age-Related Macular Degeneration Market Overview
25.2. Canada Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Age-Related Macular Degeneration Market
26.1. South America Age-Related Macular Degeneration Market Overview
26.2. South America Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Age-Related Macular Degeneration Market
27.1. Brazil Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Age-Related Macular Degeneration Market
28.1. Middle East Age-Related Macular Degeneration Market Overview
28.2. Middle East Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Age-Related Macular Degeneration Market
29.1. Africa Age-Related Macular Degeneration Market Overview
29.2. Africa Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Age-Related Macular Degeneration Market Competitive Landscape And Company Profiles
30.1. Age-Related Macular Degeneration Market Competitive Landscape
30.2. Age-Related Macular Degeneration Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Age-Related Macular Degeneration Market Other Major And Innovative Companies
31.1. Regeneron Pharmaceuticals Inc.
31.2. Amgen Inc.
31.3. Alimera Sciences Inc.
31.4. Alkeus Pharmaceuticals Inc.
31.5. AbbVie Inc.
31.6. Outlook Therapeutics Inc.
31.7. Biogen Inc.
31.8. Samsung Bioepis Co. Ltd.
31.9. Biocon Ltd.
31.10. Bio-Thera Biopharmaceutical Co. Ltd.
31.11. AstraZeneca plc
31.12. Acucela Inc.
31.13. Ophthotech Corporation
31.14. Kodiak Sciences Inc.
31.15. REGENXBIO Inc.
32. Global Age-Related Macular Degeneration Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Age-Related Macular Degeneration Market
34. Recent Developments In The Age-Related Macular Degeneration Market
35. Age-Related Macular Degeneration Market High Potential Countries, Segments and Strategies
35.1 Age-Related Macular Degeneration Market In 2029 - Countries Offering Most New Opportunities
35.2 Age-Related Macular Degeneration Market In 2029 - Segments Offering Most New Opportunities
35.3 Age-Related Macular Degeneration Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings